Avicine (original) (raw)

Avicine, tested and developed by AVI BioPharma, and also known as CTP-37 was trialled as a possible cancer vaccine to treat a number of different cancers. These included colorectal cancer, pancreatic cancer and prostate cancer. The treatment was trialled as and intended to be induced via intramuscular injection into the bloodstream, the location dependent on the treatment area.